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ABSTRACT
Dendritic cells (DCs) are the chief inducers of adaptive immunity. Their normal life cycle begins with the generation of their precursors in the bone-marrow, followed by their release into the blood stream, continues with their entry into non-lymphoid tissues and commences with steady-state or infection-induced migration into draining lymph nodes. Each of these migration steps is controlled by distinct chemokine-chemokine receptor interactions, facilitated by dynamic changes in chemokine receptor expression. In this review, we describe current knowledge on the role of chemokines and their receptors in the control of DC migratory behavior, as well as other influences on DC biology.
PRINCIPLES OF THE ROLE OF DENDRITIC CELLS IN IMMUNITY
Adaptive immune responses against infectious pathogens, tumor cells or vaccines depend on the activation of antigenspecific T cells. In order to avoid autoimmunity by autoreactive T cells that have escaped thymic censorship (1), T cell activation is tightly regulated, for example by its restriction to professional antigen-presenting cells that possess various means of distinguishing between self antigens and pathogens. Dendritic cells (DCs) are generally regarded as the most important antigen-presenting cells that facilitate T cell activation (2, 3) . After their discovery by the seminal studies of Steinman and colleagues, knowledge TNFα and iNOS production in certain bacterial infections on these cells has expanded enormously and continues to do so. Much of the current model of DC biology has been extrapolated from the analysis of DCs in lymphatic tissues of mice, and -with some exceptions-is corroborated by observations in human biopsy material. Research on DCs in non-lymphoid organs has been pioneered by studies on skin cells originally discovered by Paul Langerhans more than 100 years ago, which now have been recognized as a distinct DC subset that performs functions different to those of conventional DCs (4-6). As a further fundamental cellular subset, plasmacytoid DC have to be distinguished, which perform important innate immune functions in viral infections, such as the secretion of type I interferons, while their role as antigen-presenting cells is still unclear. In addition to distinct functionality, these DC subsets are also thought to represent distinct cell lineages that are not interconvertable when fully differentiated (7) . DCs are usually categorized by determining their cell surface molecule expression. The most commonly employed DC marker in the murine system is the integrin chain CD11c, whereas DC-SIGN seems to be more specific for human DCs (8) . In this review, we will focus on murine conventional DC and hereafter use the term "DC" to refer only to such DC. The complex biology of plasmacytoid DC has recently been reviewed elsewhere (9) .
Murine (but not human) conventional DC are often further subdivided into CD11b¯ CD8 + and CD11b + CD8¯ DC. In the past, these subsets had been referred to as "lymphoid" and "myeloid" DCs owing to the assumption that they were derived from different developmental lineages. Authoritative reviews nowadays consider these terms obsolete (3, 10) . CD8 + DCs have been shown to exhibit cross-presenting ability important for activation of cytotoxic CD8 + T cells (CTL) in antiviral and anti-tumor immune responses (4, (11) (12) (13) . They are further distinguished by expression of certain antigen uptake receptors of the C-lectin type, such as DEC-205 (14) or the mannose receptor (13) , the latter of which plays a functional role in the unique capability of DC to crosspresent exogenous antigen to naïve T cells (11, 15) . In the lung, cross-presenting DC were characterized by expression of the CD103 integrin (16) . CD11b + CD8¯ DCs possess different endocytotic C-lectin type and are specialized at activating CD4 + T cells (13, 14) . Human analogs of these two subtypes of conventional DCs remain to be defined. Further DC subtypes have been distinguished, such as TNFα-and iNOS-producing (TIP) DCs, which were essential in the innate defense against listeria monocytogenes infection (17). Table 1 summarizes the different DC subtypes and their main features.
DCs originate from hematopoietic stem cell precursors that are released into the blood (3, 18) . Many details of the DC lineage remain to be resolved, such as the question whether a common precursor, such as the monocyte, supplies tissues with both macrophages and DC subtypes (18) (19) (20) , or whether a distinct blood-borne DC precursor gives rise to DCs only (21) . It has been suggested that monocytes convert to DCs only during inflammation (3) . Recent data indicate that adoptively transferred monocytes can become DCs (22, 23) , raising the possibility that DCs in peripheral organs may arise at least to some extent from monocytes in the steady state. In lymphoid organs such as the spleen, in vivo tracking experiments supported the view that monocytes do not contribute to the DC populations in the steady state (3, 18, 22) . However, this has recently been questioned by a study that mathematically modeled splenic DC turnover in parabiosis experiments (24) . Most authorities agree that monocytes can differentiate into specialized DCs under infectious or inflammatory conditions (3, 25, 26) .
Following precursor entry into lymphoid and non-lymphoid tissue, immature DCs reside in virtually all tissues as sentinels (3, 27) and sample their environment using various endocytic mechanisms that are highly active at this stage (28) . Immature DCs are also equipped with a series of receptors for microbial molecular patterns such as Toll-like receptors (TLRs), and for inflammatory cytokines. TLR signaling fundamentally changes the chemokine receptor expression profile and initiates DC migration towards the organ-draining LNs. Upon reaching these organs, matured DCs have downregulated their endocytic activity, but upregulated expression of molecules required to activate T cells, such as MHC and costimulatory molecules and secreted cytokines (28) (29) (30) . Naïve T cells recirculate through secondary lymphatic tissues and scan immigrated DCs for presentation of their cognate antigen. T cells bearing a receptor specific for antigen captured in peripheral organs become activated and undergo vigorous proliferation, change their chemokine receptor expression profile and emigrate from the lymph nodes. Activated T cells then can enter peripheral tissues to perform immune effector functions (31) , or migrate to B cell areas in secondary lymphatic tissues where they promote antibody production.
DC biology also comprises so-called steady-state migration, where immature tissue DCs in the absence of inflammatory or infectious stimuli after some time constitutively leave the organ (3, (32) (33) (34) (35) (36) . Such immature DCs transport self antigen to draining LNs, where they usually cause T cell tolerance (3, 15, 19, 20, 33, 37) .
In addition to migratory DCs arriving from the periphery, secondary lymphoid organs also contain resident DCs, which include CD8 + and CD8 -subpopulations. These obtain antigen arriving via the lymph or from migrating DCs. Antigen handover from migratory to draining LN-resident DCs has been documented in herpes virus infection, resulting in the induction of T cell-mediated immunity (12, 38) . A further exception to the classical paradigm of DCs as antigen shuttles and T cell activators represent nonmigratory DCs, which remain in peripheral tissues despite ongoing inflammation or infection, in order to locally sustain or functionally modify immigrating effector T cells that had been activated by migratory DCs (3, 39) . Phenotypic differences between such tissue-resident DCs and migratory DCs remain to be defined.
OVERVIEW ON THE ROLE OF CHEMOKINES AND THEIR RECEPTORS IN DC BIOLOGY

Selective use of chemokines to direct migration at distinct stages of the DC life cycle
The stages of the DC life cycle are characterized by distinct cell migration patterns that are regulated by characteristic chemokine-chemokine receptor interactions ( Figure 1 ). These patterns are facilitated through controlled expression of discrete chemokine receptors, allowing cell subset-selective in vivo responses to particular chemokine signals (overview see Table 2 ).
The release of many DC precursors from the bone marrow is controlled by CXCR4 / CXCL12 (SDF-1) (40) . In inflammatory conditions such as bacterial infections, the CCR2 ligand CCL2 (MCP-1) can stimulate the release of inflammatory monocytes from the bone marrow, thereby increasing the availability of precursors for inflammatory DCs and macrophages (41, 42) . 
Recruitment of naïve T cells to licensed DCs
Costimulation of T cells The recruitment of DC precursors from the blood into inflamed peripheral tissues is thought to be controlled by CCR2 (25, (43) (44) (45) (46) (47) , although recent studies have proposed that CCR2 signaling in fact mediates DC precursor release from the bone marrow to the blood (41, 42) . DC (precursor) immigration into peripheral tissues is affected by several further chemokine receptors, in particular CCR1, CCR5 and CCR6 (46, (48) (49) (50) . The differential roles of these receptors are poorly understood. It is possible that they serve to selectively respond to the various chemokines released from the different tissues of our body, or in response to individual inflammatory or infectious conditions. Alternatively, it is conceivable that these receptors are used redundantly to avoid microbial immune escape strategies, since inhibition of several chemokine receptors is more difficult to achieve by mutation and selection than of only one mediator. A further unresolved question pertains to the mechanisms mediating tissue entry of DCs under homeostatic conditions, in order to populate tissues with resident sentinels. In some models, a role of CX 3 CR1 has been described (25, 46) .
The step of triggered DC migration from peripheral tissues into tissue-draining LNs is under control of CCR7, which guides activated DCs and naïve T cells towards each other in the priming phase of immune responses (51) . After exposure to inflammatory stimuli in peripheral tissues, DCs undergo maturation, and upregulate CCR7 (52), whereas chemokine receptors facilitating entry into inflamed tissues, such as CCR2 or CCR5 are downregulated (53) . The CCR7 chemokine ligands CCL19 (ELC, MIP-3β) and CCL21 (SLC, 6Ckine) are expressed (19, 20, 54) . There is evidence that also steady-state DC migration into draining LNs is controlled by CCR7 (32, 34, 35) . The role of chemokines in entry of DC precursors from the bloodstream into secondary lymphatics is unclear (Figure 1 ).
Tissue-specific DC recruitment by distinct chemokines
The expression profile of some chemokines, which DCs are responsive to, shows preference for certain organs, which can facilitate tissue-specific recruitment of cells expressing the cognate chemokine receptor(s). Thus, DCs expressing CCR6 and CCR9 can be attracted to mucosal tissues, where their chemokine ligands, CCL20 (LARC) and CCL25 (TECK), respectively, are produced (55, 56) . In contrast, CCL17 (TARC) or CCL22 (MDC) can be produced in the skin by DC, resulting in preferential recruitment of CCR4 + T cells towards this organ (57-59). CXCL16 produced by skin epithelial cells attracted precursors of DCs and Langerhans cells expressing the chemokine receptor CXCR6 to the epidermis (60).
Role of DC-derived chemokines in T helper-subtype differentiation
DCs not only respond to chemokines, they can also produce distinct chemokines, in order to selectively facilitate generation of Th1 and Th2-biased immune responses, and thereby recruit immune effectors suitable for the defense against viral and bacterial pathogens, or parasites, respectively (see Table 3 ). Th1 cells preferentially express CXCR3 and CCR5, and DCs can selectively produce CXCR3 ligands to attract them (61) (62) (63) DCs in peripheral tissues can originate from blood borne precursors, such as monocytes (24, 71, 72) . The bone-marrow contains a clonogenic progenitor of monocytes that can differentiate both into DCs and macrophages (18) . The egress of monocytes from the bone marrow into the circulation under non-inflammatory conditions is controlled by the chemokine CXCL12 (SDF-1), which is expressed on stromal cells (73, 74) . By interacting with its receptor CXCR4 on monocyte and DC precursors, cell surface integrins are upregulated (75) , which retain the precursors in the bone-marrow (76) . Thereby, the immune system can control the supply with DC precursors by modifying CXCL12 (SDF-1) expression (40) . CXCL12 (SDF-1) is downregulated in infectious conditions, thereby releasing more monocytes and DC precursors into the circulation (40) .
A further role of CXCR4 in DC biology has been suggested based on the recent detection of CXCR4 on plasmacytoid DCs (77) . This raised the possibility that these DCs may be infected by X4-tropic HIV, which uses this chemokine receptor to infect activated T cells (78) . The biology of plasmacytoid DCs has been reviewed recently (9).
Role of CCR2 / CCL2 (MCP-1) in recruitment of DC precursors into inflamed tissue
Under infectious conditions, tissue DCs (and macrophages) can originate from monocyte precursors, whose release from the bone marrow is under control of CCR2 / CCL2 (MCP-1) (41) . This precursor population is characterized by high expression levels of CCR2 and Gr-1 (Ly6C/G), as opposed to CCR2 LO Gr1 LO CX 3 CR1
HI monocytes, which are thought to serve as sentinels that patrol the circulation under homeostatic conditions (25) . Thus, blood monocytes consist of two main subsets of monocytes, defined by different expression levels of CCR2, CX 3 CR1 and Gr1. It has recently become possible to track Gr1 HI or Gr1 LO blood monocytes, e.g. by using distinct labeling protocols utilizing fluorescent latex beads, genetic labeling or adoptive cell transfer studies (reviewed in (47)). These techniques permit identifying the precursor cell subset that gives rise to tissue DCs and the chemokine receptor pathways employed for recruitment.
Gr1
HI monocytes have been shown to be recruited into inflamed skin or peritoneum (25, 79) , retina (80) , and after infection with Toxoplasma gondii (81) or Listeria monocytogenes (79) . In most models of acute inflammation, Gr1
HI monocyte recruitment was concluded to be critically dependent on CCR2 (44, 82), but not on CX 3 CR1 (26). Gr1
HI monocytes can give rise to macrophages, but also to conventional DC populations. Using specific monocyte-subset labeling, adoptive transfer and bone marrow chimera, Gr1 HI monocytes were identified as the circulating precursors for epidermal Langerhans cells in a model of UV-induced skin inflammation (72) .
The CCR2 ligand CCL2 (MCP-1) is produced in several organs in response to infection, and CCR2 deficient mice supported a role of this chemokine receptor in monocyte and DC infiltration into inflamed organs (83, 84) . This traditional view of CCR2-mediated immigration of monocytes from the blood into inflamed or infected tissue (43, 44, 85) has recently been challenged by the demonstration that egress of monocytes from the bone marrow into the circulation requires their expression of CCR2 (41, 42) . In this setting, CCL2 (MCP-1) produced in inflamed tissues might reach the bone-marrow via the blood stream, to promote egress of monocytes (Figure 1 ). These findings warrant revisiting prior findings showing reduced DC and macrophage recruitment into inflamed tissue of CCR2-deficient mice (43, 45) . However, ample experimental evidence remains to support an additional role of this chemokine receptor in the tissue entry of DC precursors in infection (25, 44, 46, 47) and also in autoimmunity, as CCR2, but not CCR5 or CCR6 mediated infiltration of inflammatory DCs in allergic airway inflammation (86).
Role of CCR2 / CCL2 (MCP-1) in recruitment of DC involved in innate immunity
In addition to the well-described role of DCs as inducers of adaptive immune responses, recent studies have proposed a role of conventional DCs also in innate immunity against bacterial infection (41) . In particular, a CCR2-dependent conventional DC subpopulation termed "Tip-DCs" produced TNFalpha and iNOS, which were critical for the defense against Listeria monocytogenes infection. Their absence in CCR2 deficient mice resulted in high susceptibility to this infection (17) . Tip-DCs seem to be derived from Gr1 HI monocytes (41) and have also been observed in Salmonella infection (87) and in a murine model of bacterial urinary tract infection by uropathogenic E. coli (85) . However, their contribution to overall production of these two mediators in urinary tract infection was small, and their absence in CCR2-deficient mice did not increase susceptibility to infection. Thus, Tip-DCs do not seem to be generally required for anti-bacterial innate immunity.
Role of CCR1, CCR5, CCR6, CCR8 and CCR9 in DC recruitment and migration
DCs also express the inflammatory chemokine receptors CCR1, CCR5, CCR6, CCR8 and CCR9 and appear to use them for recruitment to inflamed sites and/or to LNs (Figure 1 ). In mucosal immunity against enteroinvasive Salmonella typhimurium, CCR6 + DCs were recruited from the interfollicular regions of the Peyer's patches to the dome-region, which is located right beneath the epithelium and therefore represents a strategic position to capture pathogens from the intestinal lumen (50) . Indeed, these DCs colocalized with Salmonella-specific CD4 In general, DCs in Peyer's patches and lamina propria differentially express CCR6, and CCR6 + DCs in Peyer's patches are essential for local adaptive immune response against entero-invasive pathogens (88) . CCR6-deficient mice mounted an impaired humoral immune response to orally administered antigens and to enteropathic rotavirus. In contrast, responses to subcutaneous antigens were normal in these animals, suggesting that CCR6 is a mucosa-specific regulator of humoral immunity and of lymphocyte homeostasis in the intestinal mucosa (88) . In line, repopulation of inflamed skin by dermal DCs requires CCR2, but not CCR6 (89) . In sterile lung inflammation, DCs also used CCR6 for recruitment from the bloodstream, in order to traverse alveolar epithelium (90) . They also required CCR2 for this purpose, in order to cross vascular endothelium (90) . Another chemokine receptor specifically relevant in DC migration in the intestine under inflammatory conditions may be CCR9, as CCR9-dependent recruitment of plasmacytoid DCs is a prerequisite for the rapid mobilization of conventional DCs from the lamina propria (91) .
CCR5 contributed to inflammatory recruitment of mononuclear phagocytes and DCs in several models. In thermal cornea damage, it mediated recruitment of DCs towards inflammation (48) . In diet-induced atherosclerosis in ApoE -/-mice, lack of CCR5, but not of CCR1, reduced monocyte infiltration and ameliorated atherosclerosis (92) . CCR5 appears to be employed by both monocyte subsets for emigration into atherosclerotic lesions (46) . There is most likely functional redundancy between these receptors, since two of the three chemokine ligands of CCR5 also bind to CCR1 (CCL3=MIP-1a and CCL5=RANTES), as demonstrated using in vitro transmigration assays (93) . Furthermore, CCR5 is expressed also on activated T cells (94) , including regulatory T cells (95) , so that biological effects observed in knockout mice often cannot be easily attributed to DCs. Apart from effects on DC migration and its role as co-receptor for HIV entry (see above), CCR5 has recently been shown to act as a pattern recognition receptor for a mycobacterial heat shock protein, which triggered DC maturation (96) . Also, it has been shown to be recruited to the immunological synapse of DCs, where it increased costimulation of T cells during priming (49) . Finally, an indirect role of CCR5 in DC biology has been described in classical cross-priming, where CD4 + T cells engaged in licensing cross-presenting DCs (97) secreted the CCR5 ligands CCL3 (MIP-1a) and CCL4 (MIP-1b), which recruited naïve CD8 T cells towards the DCs for activation (98) .
Little is known about the function of CCR8 that is highly expressed by monocyte-derived DCs in models using intradermal injection of particulate antigens. However, similar to CCR7, monocyte-derived DCs have been shown to use it for migration to the skin-draining lymph node (26).
CX3CR1-mediated effects on DCs
Virtually all organs contain a network of resident DCs, which is thought to serve as a sentinel system against microbes or other inflammatory challenges (27) . Especially dense networks have been described in the kidney (99, 100) and in the gut (50) . These resident DCs can be visualized particularly well with the use of transgenic mice expressing green fluorescent protein instead of one of the two CX 3 CR1 genes under control of its natural promoter (25) . Intravital microscopy revealed that interstitial GFP + DCs continually probed the surrounding tissue environment using dendrite extensions. These observations have led to the hypothesis that resident DCs use CX 3 CR1 to enter non-inflamed tissues. Conclusive results have been found in the lung, where Gr-1 LO CX 3 CR1 HI monocytes appeared to contribute to the turnover of pulmonary DC populations in the steady state (23) . However, Gr-1 HI monocytes (expressing comparatively low levels of CX 3 CR1) used CX 3 CR1 for emigration into atherosclerotic lesions of chronically inflamed vasculature, as opposed to their Gr-1 LO counterparts (46) . This suggests that different mechanisms may exist for CX 3 CR1-dependent recruitment under homeostatic and inflammatory conditions. Furthermore, the expression of CX 3 CR1 by DCs in the tissue does not allow to directly draw conclusions about their precursor, as cell may up-or downregulate CX 3 CR1 during their differentiation.
In the small intestine, lamina propria DCs were reported to require CX 3 CR1 for formation of transepithelial dendrites, which were required for acquisition of luminal bacterial antigens and for clearance of entero-invasive pathogens (50) . The general relevance of these findings for intestinal infections is unclear, as it was later shown that TLR signaling by gut epithelial cells was responsible for such dendrite formation (101) and that acquisition of a fungal antigen did not require these dendrites at all (102) . In the inflamed cornea, CX 3 CR1 was required for DC recruitment into the stroma and epithelium (103) . The involvement of CX 3 CR1 in inflammatory DC recruitment sheds further doubt on the proposed dichotomy of CX 3 CR1-dependent monocytes for homeostatic DCs, and CCR2-dependent monocytes for inflammatory DC recruitment.
CCL19 (ELC, MIP-3beta) and CCL21 (SLC, 6Ckine) -mediated effects on DCs via CCR7
DC migration triggered by microbial stimuli or by inflammatory cytokines (104) is accompanied by fundamental changes in the chemokine receptor expression profile, such as downregulation of CCR2 and CCR5 (53), which mediate tissue immigration from the bloodstream, and upregulation of CCR7 or CCR4 (52) . CCR7 is the dominant chemokine receptor mediating migration of DCs to draining LNs (Figure 1) (51) . In CCR7-deficient mice, DC migration from the skin, gut, eye and lung into draining LNs was reported to be severely impaired (32, 34, 35, 51, 105) . In order to reach these LNs, DCs first have to enter the lymphatics possibly via adhesion molecules such as ICAM -1 or JAM-1 (20) . DCs migrate towards CCL21 (SLC, 6Ckine)-leu expressed inside of lymphatic vessels, resulting in their arrival in the subcapsular sinus of the draining LN (19, 20, 106) . There they are further directed towards the paracortex by CCL21 (SLC, 6Ckine) -ser or CCL19 (ELC, MIP-3β) derived from stroma cells and high endothelial venules in order to reach the site of T cell activation (19, 107) . Maturing DCs can also produce CCL19 themselves, and thereby induce signaling involved in rearrangement of the cytoskeleton (52, 54) . Therefore, DCs may use paracrine or autocrine mechanisms for CCR7-dependent migration. However, the expression of CCR7 alone is not sufficient for DC migration. Further signals such as lipid mediators, cysteinyl leukotriens, prostaglandin E 2 , and CD38 are required to sensitize CCR7 to its ligands CCL19 (ELC, MIP-3beta) and CCL21 (SLC, 6Ckine) (20) . Possibly, these mediators alter intracellular signaling pathways, but the exact mechanisms are unclear. Additional factors described to influence DC migration include sphingosine-1-phosphate (108), histamine, adenosine, and prostaglandin-D 2 (20) .
In the absence of inflammation, CCR7-dependent constitutive migration of immature DCs to organ-draining LN has been observed, for example in the skin (35) . Such "steady-state" DC migration is thought to be important for peripheral T cell tolerance against organ-derived antigens (2) . Tolerogenic cross-presentation of antigen to CD8 + T cells (cross-tolerance) has been shown to apply to pancreatic or kidney self antigen in the respective organdraining LN (15, 37) . It is unresolved whether crosstolerizing DCs were migratory or whether LN-resident CD8 + DCs after capturing antigen from organ derived steady-state migrating ones mediated tolerance.
CCR7 not only acts as a chemotactic receptor on DCs. Both its ligands increase the endocytotic capability of DCs (109) . Furthermore, CCR7 protected human monocyte-derived DCs from apoptosis induced by serum deprivation (110) . Both CCL19 and CCL21 have been reported to induce DC maturation, upregulation of costimulatory molecules such as CD80 and CD86 and result in secretion of inflammatory cytokines such as IL-12, TNFα and IL-1 (111) . Furthermore, DCs from paucity of lymph nodes (plt) mice, a natural mutation deficient for CCL21-ser (SLC, 6Ckine) and CCL19 (ELC, MIP-3beta), showed reduced maturation (112) . To mediate such diverse cellular effects, CCR7 engages various signaling pathways (54) . In DCs, cdc42-rac mediates endocytosis, whereas PI3 kinase controls cell survival (54) . The selective effects of CCL19 (ELC, MIP-3beta) and CCL21 (SLC, 6Ckine) in regulation of DC survival, maturation, and chemotaxis are generally difficult to distinguish.
Effect of CCL17 (TARC) and CCL22 (MDC) produced by DCs on T cells via CCR4
In mice, CCL17 (TARC) was originally identified by comparing gene expression profiles between macrophages and bone marrow-derived DCs (113) . In vivo it is expressed by thymic DCs and by DCs in lymph nodes and in the lung. No expression was found in B or T cells (113, 114) . Recombinant murine CCL17 (TARC) lacked chemotactic activity on naive CD4 + T cells, but attracted antigen-primed CD4 + T cells with preference for the Th2 phenotype by interacting with CCR4 (113) . This in vitro observation was confirmed in vivo using murine Th2-dependent disease models, for example allergic airway inflammation (115) or atopic dermatitis (116) . Mice deficient for CCL17 (TARC) showed diminished T-cell dependent contact hypersensitivity and delayed allogeneic rejection of heart transplants (114) . Interestingly, CCL17 (TARC) was not detected in the spleen, even in the presence of systemic bacterial infection (114) . A functional involvement of CCL17 (TARC) was demonstrated in LPSand in Propionibacterium acnes-induced fulminant hepatitis, where it recruited IL-4 producing and liverinfiltrating CCR4 + CD4 T cells (117) .
The CCL17-receptor CCR4 has been detected on Langerhans cells, monocytes, NK cells, platelets, memory T cells and CD25 + regulatory T cells (53, 114, 118) . It also recognizes CCL22 (MDC=macrophage-derived chemokine) (67) , whose function is less defined than that of CCL17 (TARC). CCR4 mediated homing of CD4 T cells to the skin, but not to mucosal tissue (59) . Both the production of CCL17 (TARC) by mature DCs and the expression of CCR4 on T cells, as well as functional studies (119) suggest that it promotes T-cell-DC interaction during antigen specific activation. It is unknown whether CCL17 (TARC) exerts cell-intrinsic CCR4-mediated effects on T cells during priming. Recent studies highlighted an additional role of CCR4 for the trafficking of regulatory T cells in inflammatory models, e.g. of inflammatory bowel disease (120, 121) .
Despite the often cited association of CCL17 (TARC) and CCR4 with Th2 polarization (67), the CCR4-deficient mouse showed unimpaired Th2 response, but unexpectedly was protected from LPS-induced endotoxic shock (122) . Furthermore, allograft rejection was delayed in these animals (123) . Consistent with these findings, CCL17 (TARC) is strongly upregulated in DCs in response to various TLR ligands, correlating with increased production of Th1 cytokines such as IL-12 (114) . Thus, the paradigm of the Th2 association of CCR4-CCL17 responses seems to require further studies. In the T cell activation phase, DCs inducing Th1 responses selectively produced CXCR3 ligands in order to retain Th1-commited T cells in the lymph node for optimal priming (26) . During the effector phase, CXCR3 ligands produced by tissue-resident DCs and/or by intrinsic tissue cells recruited Th1 effector T cells from the circulation to the site of injury, for example in delayed type hypersensitivity responses (126, 127) . Interestingly, CXCR3 is used by activated CD8 + effector T cells also for entry into lymph nodes and for killing CXCR3-ligandproducing DCs that present cognate antigen, perhaps in order to prevent further priming of specific CD8 + T cells after sufficient of these cells have been generated (128) . Thus, CXCR3 appears to drive Th1 responses not only in the priming phase of adaptive immunity in draining lymph nodes, but also in the effector phase in peripheral and lymphoid tissues. As all of the three CXCR3 ligands are specific agonists for this receptor (61, 62) , and even appear to act as antagonists for the Th2 chemokine receptor CCR3 (129) , it is currently thought that CXCR3 signaling is used by the immune system to selectively induce Th1 immunity.
Effect of CXCL9 (MIG)
Also in various Th1-type inflammatory diseases, a role of CXCR3-signaling has been observed, e.g. rheumatoid arthritis (65) , multiple sclerosis (61), skin diseases (126, 130, 131) , type 1 diabetes (132), lung, bowel and renal transplant rejection (62, 133, 134) and glomerulonephritis (127, 135) , as evidenced by protection of CXCR3-deficient mice in murine models of these diseases. Concurrent expression of the three CXCR3 ligands is observed in many disease models, such as the tubulointerstitial kidney compartment (136, 137) , where DCs are abundant (99) or in the lung (134) . However, in most of these studies, the exact cellular source of these chemokines was not elucidated, so that the contribution of DCs to their production remains to be clarified. In HIV infection, virally infected DCs selectively expressed CXCL10 (IP10) and 11 (ITAC), which was interpreted as viral strategy to attract CD4 T cells towards infected cells for purposes of viral spreading.
Interestingly, in some disease models, genetic or antibody-mediated incapacitation of CXCL10 (IP10) was sufficient for protection (138, 139) , demonstrating preferential use of only one of the three CXCR3 ligands. Similar observations were also made in infection models, which were exacerbated after blocking of individual chemokines (134, 140) . It is unknown, whether this was due to differences in the cellular or tissue expression profile of the chemokines, or to particularities of the infectious condition studied.
VIRAL EXPLOITATION OF CHEMOKINES RECEPTORS EXPRESSED BY DCS
Many viruses exploit chemokines or their receptors for purposes of infection. Probably the best known example is the essential role of CCR5 in entry of C5-trophic HIV into monocytes, DCs and macrophages, which allows the virus to spread into deep tissue compartments (141, 142). Based on the resistance of individuals bearing a mutation of CCR5 to HIV infection, therapeutical trials using CCR5 inhibitors are currently being performed (143).
The human cytomegalovirus uses a different strategy to exploits the chemokine system: It downregulates CCR1 and CCR5 in infected DCs, and thereby inhibits induction of adaptive immunity by impairing DC migration (144) . Moreover, it causes production of a soluble chemokine receptor analogon, which can bind and incapacitate several chemokines such as the CCR5 ligand CCL4 (MIP-1b) (145) . A further example is the poxvirus molluscum contagiosum, which produces a CCR8 inhibitor capable of inhibiting migration of human monocytes and DCs (146) . More information of these and several other cases of viral exploits of the chemokine system can be found in specialized reviews (147, 148) .
CONCLUDING REMARKS
The different stages of the DC life cycle are stringently controlled by distinct chemokines and their receptors. Some of these mechanisms have recently been elucidated, but many remain unresolved or controversial. Exact knowledge of these mechanisms is crucial not only for understanding basic immune mechanisms, such as those regulating DC lineage and migration, or microbial immune escape, but may also facilitate the development of novel therapeutic strategies aimed at selectively modifying DC responses. Recent advances in the use of chemokine receptor inhibitors highlight their potential for designing more effective therapies with fewer side effects (149, 150 
